Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurofibromatosis 1 and 2 (NF1 and NF2)”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Testing effectiveness (Phase 2)Study completedNCT01419639
What this trial is testing

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

Who this might be right for
Neurofibromatosis Type II
NYU Langone Health 10
Not applicableStudy completedNCT02246231
What this trial is testing

Effect of Implant Position on Magnetic Resonance Image Distortion

Who this might be right for
Neurofibromatosis Type 2
Manchester University NHS Foundation Trust 5
Testing effectiveness (Phase 2)Ended earlyNCT01345136
What this trial is testing

Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma

Who this might be right for
Neurofibromatosis Type 2Neuroma, Acoustic
Jonsson Comprehensive Cancer Center 4
Not applicableUnknownNCT05685836
What this trial is testing

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Who this might be right for
Neurofibromatosis 2
Leiden University Medical Center 15
Not applicableLooking for participantsNCT03050268
What this trial is testing

Familial Investigations of Childhood Cancer Predisposition

Who this might be right for
Acute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more
St. Jude Children's Research Hospital 1,500
Large-scale testing (Phase 3)Ended earlyNCT03710564
What this trial is testing

Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 535
Not applicableEnded earlyNCT01864291
What this trial is testing

Auditory Brainstem Implant (ABI) in Pediatric Non-Neurofibromatosis Type 2 Subjects

Who this might be right for
Bilateral Hearing Loss for Causes Other Than Tumors
Massachusetts Eye and Ear Infirmary 9
Testing effectiveness (Phase 2)Ended earlyNCT03095248
What this trial is testing

Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors

Who this might be right for
Neurofibromatosis 2Vestibular SchwannomaMeningioma+2 more
Children's Hospital Medical Center, Cincinnati 10
Not applicableStudy completedNCT03617276
What this trial is testing

Reliability of Functional Outcome Measures in Neurofibromatosis 2

Who this might be right for
Neurofibromatosis 2
Guy's and St Thomas' NHS Foundation Trust 30
Early research (Phase 1)Study completedNCT00030043
What this trial is testing

An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors

Who this might be right for
Neurofibromatosis 2
FDA Office of Orphan Products Development 10
Not applicableNo Longer AvailableNCT02589912
What this trial is testing

Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients

Who this might be right for
Neurofibromatosis Type 2Severe Profound Sensorineural Hearing Loss
Massachusetts Eye and Ear Infirmary
Not applicableLooking for participantsNCT01885767
What this trial is testing

Neurofibromatosis (NF) Registry Portal

Who this might be right for
Neurofibromatosis 1Neurofibromatosis 2Schwannomatosis
The Children's Tumor Foundation 20,000
Not applicableUnknownNCT04890132
What this trial is testing

Vestibular Precision: Physiology & Pathophysiology

Who this might be right for
Vestibular SchwannomaInner Ear DiseaseDizziness+2 more
Massachusetts Eye and Ear Infirmary 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03079999
What this trial is testing

Study of Aspirin in Patients With Vestibular Schwannoma

Who this might be right for
Vestibular SchwannomaAcoustic NeuromaNeurofibromatosis 2
Massachusetts Eye and Ear Infirmary 97
Early research (Phase 1)WithdrawnNCT01850225
What this trial is testing

Feasibility Study of Auditory Brainstem Implant in Young Children

Who this might be right for
Bilateral Cochlear AplasiaBilateral Cochlear Nerve DeficiencyBilateral Cochlear Ossification Secondary to Meningitis
House Research Institute
Not applicableStudy completedNCT02811718
What this trial is testing

Resiliency Training for Patients With NF2 Via Videoconferencing With Skype

Who this might be right for
Neurofibromatosis 2
Massachusetts General Hospital 45
Testing effectiveness (Phase 2)Ended earlyNCT00911248
What this trial is testing

PTC299 for Treatment of Neurofibromatosis Type 2

Who this might be right for
Neurofibromatosis 2
PTC Therapeutics 11
Testing effectiveness (Phase 2)Study completedNCT02934256
What this trial is testing

Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Who this might be right for
Vestibular SchwannomaNeurofibromatosis Type 2
Li Peng 10
Not applicableStudy completedNCT02435628
What this trial is testing

Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With NF

Who this might be right for
Neurofibromatosis
Massachusetts General Hospital 86
Not applicableStudy completedNCT03672838
What this trial is testing

A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)

Who this might be right for
Neurofibromatosis 1 and 2 (NF1 and NF2)
NYU Langone Health 33
Load More Results